Multimodal gnaq signaling: precision therapy for metastatic uveal melanoma prevention and treatment
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110822
- Recipient
-
Thomas Jefferson University UEI R8JEVL4ULGB7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $234,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Philadelphia, PA 19107, USA
Award details come from USAspending.gov.
About this award
Thomas Jefferson University, doing business as Sidney Kimmel Medical College, was awarded a $234,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program.
The three-year grant will fund research into precision therapies for metastatic uveal melanoma prevention and treatment by investigating multimodal GNAQ signaling pathways. Through September 2021 to August 2024, Sidney Kimmel Medical College researchers will work to transform patient care and advance scientific knowledge of medical solutions for battlefield injuries, as outlined under the Military Medical Research and Development program's goals. Findings have the potential to improve health outcomes for service members and the general public.
Quick answers
Who received award W81XWH2110822?
W81XWH2110822 was awarded to Thomas Jefferson University by Medical Command (Department of the Army) on September 1, 2021.
How much is award W81XWH2110822 worth?
$234,000 has been obligated on W81XWH2110822.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award